Interest-activity symptom severity predicts response to ketamine infusion in treatment-resistant depression

被引：0
|
作者：
Mu-Hong Chen
Wei-Chen Lin
Hui-Ju Wu
Ya-Mei Bai
Cheng-Ta Li
Shih-Jen Tsai
Chen-Jee Hong
Pei-Chi Tu
Tung-Ping Su
机构：
[1] Taipei Veterans General Hospital,Department of Psychiatry
[2] National Yang-Ming University,Division of Psychiatry, Faculty of Medicine
[3] National Yang-Ming University,Institute of Brain Science
[4] Taipei Veterans General Hospital,Department of Medical Research
[5] Cheng Hsin General Hospital,Department of Psychiatry
来源：
Psychopharmacology | 2021年 / 238卷
关键词：
Ketamine; Treatment-resistant depression; Interest-activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 865
页数：8
相关论文
共 50 条
  • [1] Interest-activity symptom severity predicts response to ketamine infusion in treatment-resistant depression
    Chen, Mu-Hong
    Lin, Wei-Chen
    Wu, Hui-Ju
    Bai, Ya-Mei
    Li, Cheng-Ta
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Su, Tung-Ping
    [J]. PSYCHOPHARMACOLOGY, 2021, 238 (03) : 857 - 865
  • [2] Functional Dysconnectivity of Frontal Cortex to Striatum Predicts Ketamine Infusion Response in Treatment-Resistant Depression
    Chen, Mu-Hong
    Chang, Wan-Chen
    Lin, Wei-Chen
    Tu, Pei-Chi
    Li, Cheng-Ta
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Huang, Wen-Sheng
    Su, Tung-Ping
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2020, 23 (12): : 791 - 798
  • [3] Treatment-Resistant Depression: Program Development for Ketamine Infusion
    Miller, Courtney
    Bolton, Paula
    [J]. JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2019, 25 (04) : 332 - 332
  • [4] Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression
    Jesus-Nunes, Ana Paula
    Leal, Gustavo C.
    Correia-Melo, Fernanda S.
    Vieira, Flavia
    Mello, Rodrigo P.
    Caliman-Fontes, Ana Teresa
    Echegaray, Mariana V. F.
    Marback, Roberta F.
    Guerreiro-Costa, Livia N. F.
    Souza-Marques, Breno
    Santos-Lima, Cassio
    Souza, Lucca S.
    Bandeira, Igor D.
    Kapczinski, Flavio
    Lacerda, Acioly L. T.
    Quarantini, Lucas C.
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (04)
  • [5] Dissociative symptoms predict antidepressant response after infusion of ketamine in treatment-resistant depression
    Echegaray, M. V. F.
    Mello, R.
    Correia-Melo, F. S.
    Leal, G. C.
    Jesus-Nunes, A. P.
    Vieira, F.
    Fontes, A. T. C.
    Beanes, G.
    Magnavita, G.
    Bandeira, I. D.
    Lacerda, A. L. T.
    Quarantini, L. C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S321 - S322
  • [6] Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response: Reexploring the Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression
    Chen, Mu-Hong
    Lin, Wei-Chen
    Wu, Hui-Ju
    Bai, Ya-Mei
    Li, Cheng-Ta
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Cheng, Chih-Ming
    Su, Tung-Ping
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (06)
  • [7] Inflammation, Depression Severity, and Response to Ketamine in Treatment-Resistant Depressed Patients: Sex Differences
    Kruse, Jennifer
    Hellemann, Gerhard
    Olmstead, Richard
    Jiang, Janina
    Congdon, Eliza
    Espinoza, Randall
    Narr, Katherine
    Irwin, Michael
    [J]. NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 120 - 120
  • [8] Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression
    Chen, Mu-Hong
    Wu, Hui-Ju
    Li, Cheng-Ta
    Lin, Wei-Chen
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Mao, Wei-Chung
    Su, Tung-Ping
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (02)
  • [9] Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression
    Kwasny, Aleksander
    Cubala, Wieslaw Jerzy
    Wlodarczyk, Adam
    [J]. FRONTIERS IN PSYCHIATRY, 2024, 15
  • [10] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
12345